North America Peritoneal Dialysis Market Size, Share, Trends & Analysis by Product (Peritoneal Solution, Peritoneal Dialysis Catheters, Implantation Systems, Other Accessories), by Treatment Type (Automated Peritoneal Dialysis (APD), Continuous Ambulatory Peritoneal Dialysis (CAPD)), by End-User (Hospitals, Homecare Settings, Dialysis Centers) and Region, with Forecasts from 2024 to 2034.

Market Overview

 

The North America Peritoneal Dialysis Market is poised for substantial growth from 2024 to 2034, fueled by an increasing prevalence of end-stage renal disease (ESRD), a growing preference for home-based dialysis treatments, and continuous advancements in peritoneal dialysis technology. The market size is anticipated to expand from USD XXX.XX billion in 2024 to USD XX.XX billion by 2034, registering a compound annual growth rate (CAGR) of XX.XX%. Key factors driving this growth include:

 

• Rising ESRD Cases: The increasing incidence of ESRD, largely driven by the growing prevalence of diabetes and hypertension, is significantly boosting the demand for peritoneal dialysis as an alternative to hemodialysis.

 

• Advancements in Dialysis Products: Ongoing innovations in peritoneal dialysis products, including solutions, catheters, and implantation systems, are enhancing the efficacy and safety of peritoneal dialysis, contributing to market growth.

 

• Shift Towards Home-Based Treatments: The growing preference for home-based dialysis, driven by patient convenience, lower infection risks, and healthcare cost savings, is accelerating the adoption of peritoneal dialysis in North America.

 

Definition and Scope of Peritoneal Dialysis

 

Peritoneal Dialysis (PD) is a renal replacement therapy that involves the removal of waste products and excess fluids from the blood using the peritoneum as a natural filter. PD is commonly used for patients with chronic kidney disease (CKD) and ESRD as an alternative to hemodialysis. The treatment is typically categorized into two main types: Automated Peritoneal Dialysis (APD), which is performed using a machine that cycles the dialysis solution automatically, and Continuous Ambulatory Peritoneal Dialysis (CAPD), a manual method that allows patients to perform dialysis during their daily activities.

 

Market Drivers

 

• Increasing ESRD Prevalence: The growing number of patients with ESRD in North America is a major driver of the peritoneal dialysis market. Factors such as the rising incidence of diabetes and hypertension, which are leading causes of ESRD, are contributing to this trend.

 

• Technological Advancements: Innovations in PD products, including more efficient and patient-friendly peritoneal solutions, catheters, and implantation systems, are improving treatment outcomes and patient adherence, thereby driving market growth.

 

• Growing Preference for Homecare: The increasing preference for home-based PD, supported by advancements in portable dialysis machines and telehealth services, is driving the market as patients seek greater convenience and flexibility in managing their condition.

 

Market Restraints

 

• Risk of Peritonitis: The risk of peritonitis, a common and serious infection associated with peritoneal dialysis, remains a significant concern that may limit the widespread adoption of PD.

 

• High Treatment Costs: While PD offers convenience, the cost of supplies, equipment, and ongoing care can be a barrier for some patients, particularly those without adequate insurance coverage.

 

Opportunities

 

• Innovations in PD Technology: The development of more advanced and patient-friendly PD technologies, such as wearable dialysis devices and enhanced biocompatible solutions, presents significant growth opportunities.

 

• Expansion of Homecare Services: The expansion of homecare services, supported by telemedicine and remote monitoring technologies, can further drive the adoption of PD, particularly in rural and underserved areas.

 

• Collaborative Research and Development: Collaboration between healthcare providers, pharmaceutical companies, and medical device manufacturers can lead to the development of more effective PD solutions and improve patient outcomes.

 

Market Segmentation Analysis

 

• By Product

    ○ Peritoneal Solution

    ○ Peritoneal Dialysis Catheters

    ○ Implantation Systems

    ○ Other Accessories

 

• By Treatment Type

    ○ Automated Peritoneal Dialysis (APD)

    ○ Continuous Ambulatory Peritoneal Dialysis (CAPD)

 

• By End-User

    ○ Hospitals

    ○ Homecare Settings

    ○ Dialysis Centers

 

Regional Analysis

 

• United States: The U.S. is expected to dominate the North America Peritoneal Dialysis Market, driven by its advanced healthcare infrastructure, high ESRD prevalence, and growing adoption of home-based treatments.

 

• Canada: Canada is witnessing increasing adoption of PD due to its well-established healthcare system, government initiatives supporting homecare, and growing patient awareness.

 

• Mexico: The peritoneal dialysis market in Mexico is expected to grow steadily, supported by improving healthcare infrastructure and increasing access to dialysis treatments.

 

The North America Peritoneal Dialysis Market is set to experience significant growth over the forecast period, driven by rising ESRD cases, technological advancements, and increasing preference for home-based treatments. Despite challenges such as the risk of peritonitis and high treatment costs, the market presents ample opportunities for innovation and expansion.

 

Competitive Landscape

 

Key players in the North America Peritoneal Dialysis Market include:

 

Baxter International Inc.

Fresenius Medical Care AG & Co. KGaA

Medtronic plc

B. Braun Melsungen AG

Nipro Corporation

Terumo Corporation

DaVita Inc.

Dialysis Clinic, Inc.

Asahi Kasei Medical Co., Ltd.

Renal Care Group, Inc.

Table of Contents:

 

1. Introduction

    1.1. Definition of Peritoneal Dialysis

    1.2. Scope of the Report

    1.3. Research Methodology

 

2. Executive Summary

    2.1. Key Findings

    2.2. Market Snapshot

    2.3. Key Trends

 

3. Market Dynamics

    3.1. Market Drivers

        3.1.1. Rising Prevalence of End-Stage Renal Disease (ESRD)

        3.1.2. Growing Preference for Home-based Dialysis

        3.1.3. Technological Advancements in Peritoneal Dialysis Products

        3.1.4. Increasing Government Support and Funding

    3.2. Market Restraints

        3.2.1. High Cost of Peritoneal Dialysis Treatment

        3.2.2. Risk of Infections and Complications

        3.2.3. Limited Awareness and Expertise in Peritoneal Dialysis

    3.3. Market Opportunities

        3.3.1. Development of Novel and Improved Dialysis Products

        3.3.2. Expansion of Healthcare Infrastructure

        3.3.3. Growing Adoption of Automated Peritoneal Dialysis (APD)

        3.3.4. Strategic Collaborations and Partnerships

 

4. North America Peritoneal Dialysis Market Analysis

    4.1. Market Size and Forecast (2024-2034)

    4.2. Market Share Analysis by:

        4.2.1. Product

            4.2.1.1. Peritoneal Solution

            4.2.1.2. Peritoneal Dialysis Catheters

            4.2.1.3. Implantation Systems

            4.2.1.4. Other Accessories

        4.2.2. Treatment Type

            4.2.2.1. Automated Peritoneal Dialysis (APD)

            4.2.2.2. Continuous Ambulatory Peritoneal Dialysis (CAPD)

        4.2.3. End-User

            4.2.3.1. Hospitals

            4.2.3.2. Homecare Settings

            4.2.3.3. Dialysis Centers

    4.3. Value Chain Analysis

    4.4. SWOT Analysis

    4.5. Porter’s Five Forces Analysis

 

5. Regional Market Analysis

    5.1. United States

        5.1.1. Market Overview

        5.1.2. Market Size and Forecast

        5.1.3. Key Trends

        5.1.4. Competitive Landscape

    5.2. Canada

        5.2.1. Market Overview

        5.2.2. Market Size and Forecast

        5.2.3. Key Trends

        5.2.4. Competitive Landscape

    5.3. Mexico

        5.3.1. Market Overview

        5.3.2. Market Size and Forecast

        5.3.3. Key Trends

        5.3.4. Competitive Landscape

 

6. Competitive Landscape

    6.1. Market Share Analysis of Key Players

    6.2. Company Profiles of Key Players

        6.2.1. Baxter International Inc.

        6.2.2. Fresenius Medical Care AG & Co. KGaA

        6.2.3. Medtronic plc

        6.2.4. B. Braun Melsungen AG

        6.2.5. Nipro Corporation

        6.2.6. Terumo Corporation

        6.2.7. DaVita Inc.

        6.2.8. Dialysis Clinic, Inc.

        6.2.9. Asahi Kasei Medical Co., Ltd.

        6.2.10. Renal Care Group, Inc.

    6.3. Recent Developments and Innovations

    6.4. Strategic Initiatives

 

7. Future Outlook and Market Forecast

    7.1. Market Growth Prospects

    7.2. Technological Trends and Innovations

    7.3. Investment Opportunities

    7.4. Strategic Recommendations

 

8. Key Insights and Reiteration of Main Findings

9. Future Prospects for the North America Peritoneal Dialysis Market

 

List of Tables:

 

Table 1: North America Peritoneal Dialysis Market, By Product, 2024-2034 (USD Million)

Table 2: North America Peritoneal Dialysis Market, By Treatment Type, 2024-2034 (USD Million)

Table 3: North America Peritoneal Dialysis Market, By End-User, 2024-2034 (USD Million)

Table 4: North America Peritoneal Dialysis Market Revenue by Country, 2024-2034 (USD Million)

Table 5: North America Peritoneal Dialysis Market Volume by Country, 2024-2034 (Units)

Table 6: United States Peritoneal Dialysis Market, By Product, 2024-2034 (USD Million)

Table 7: United States Peritoneal Dialysis Market, By Treatment Type, 2024-2034 (USD Million)

Table 8: United States Peritoneal Dialysis Market, By End-User, 2024-2034 (USD Million)

Table 9: Canada Peritoneal Dialysis Market, By Product, 2024-2034 (USD Million)

Table 10: Canada Peritoneal Dialysis Market, By Treatment Type, 2024-2034 (USD Million)

Table 11: Canada Peritoneal Dialysis Market, By End-User, 2024-2034 (USD Million)

Table 12: Mexico Peritoneal Dialysis Market, By Product, 2024-2034 (USD Million)

Table 13: Mexico Peritoneal Dialysis Market, By Treatment Type, 2024-2034 (USD Million)

Table 14: Mexico Peritoneal Dialysis Market, By End-User, 2024-2034 (USD Million)

Table 15: North America Peritoneal Solution Market Revenue by Country, 2024-2034 (USD Million)

Table 16: North America Peritoneal Dialysis Catheters Market Revenue by Country, 2024-2034 (USD Million)

Table 17: North America Implantation Systems Market Revenue by Country, 2024-2034 (USD Million)

Table 18: North America Automated Peritoneal Dialysis (APD) Market Revenue by Country, 2024-2034 (USD Million)

Table 19: North America Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Revenue by Country, 2024-2034 (USD Million)

Table 20: North America Hospitals Market Revenue by Country, 2024-2034 (USD Million)

Table 21: North America Homecare Settings Market Revenue by Country, 2024-2034 (USD Million)

Table 22: North America Dialysis Centers Market Revenue by Country, 2024-2034 (USD Million)

Table 23: North America Peritoneal Dialysis Market Revenue by Major Companies, 2024-2034 (USD Million)

Table 24: North America Peritoneal Dialysis Market Volume by Major Companies, 2024-2034 (Units)

Table 25: Baxter International Inc.: Company Snapshot

Table 26: Baxter International Inc.: Operating Segments

Table 27: Baxter International Inc.: Product Portfolio

Table 28: Fresenius Medical Care AG & Co. KGaA: Company Snapshot

Table 29: Fresenius Medical Care AG & Co. KGaA: Operating Segments

Table 30: Fresenius Medical Care AG & Co. KGaA: Product Portfolio

Table 31: Medtronic plc: Company Snapshot

Table 32: Medtronic plc: Operating Segments

Table 33: Medtronic plc: Product Portfolio

 

List of Figures:

 

Figure 1: North America Peritoneal Dialysis Market: Market Segmentation

Figure 2: North America Peritoneal Dialysis Market: Research Methodology

Figure 3: Top Down Approach

Figure 4: Bottom Up Approach

Figure 5: Data Triangulation and Validation

Figure 6: North America Peritoneal Dialysis Market: Drivers, Restraints, Opportunities, and Challenges

Figure 7: North America Peritoneal Dialysis Market: Porter's Five Forces Model Analysis

Figure 8: North America Peritoneal Dialysis Market: Value Chain Analysis

Figure 9: North America Peritoneal Dialysis Market Share Analysis, By Product, 2024-2034

Figure 10: North America Peritoneal Dialysis Market Share Analysis, By Treatment Type, 2024-2034

Figure 11: North America Peritoneal Dialysis Market Share Analysis, By End-User, 2024-2034

Figure 12: United States Peritoneal Dialysis Market Share Analysis, By Product, 2024-2034

Figure 13: United States Peritoneal Dialysis Market Share Analysis, By Treatment Type, 2024-2034

Figure 14: United States Peritoneal Dialysis Market Share Analysis, By End-User, 2024-2034

Figure 15: Canada Peritoneal Dialysis Market Share Analysis, By Product, 2024-2034

Figure 16: Canada Peritoneal Dialysis Market Share Analysis, By Treatment Type, 2024-2034

Figure 17: Canada Peritoneal Dialysis Market Share Analysis, By End-User, 2024-2034

Figure 18: Mexico Peritoneal Dialysis Market Share Analysis, By Product, 2024-2034

Figure 19: Mexico Peritoneal Dialysis Market Share Analysis, By Treatment Type, 2024-2034

Figure 20: Mexico Peritoneal Dialysis Market Share Analysis, By End-User, 2024-2034

Figure 21: North America Peritoneal Dialysis Market: Competitive Benchmarking

Figure 22: North America Peritoneal Dialysis Market: Vendor Share Analysis, 2024

Figure 23: North America Peritoneal Dialysis Market: Regulatory Landscape

Figure 24: North America Peritoneal Dialysis Market: Technological Innovations

Figure 25: North America Peritoneal Dialysis Market: Sustainability Trends

Figure 26: North America Peritoneal Dialysis Market: Future Outlook

Figure 27: North America Peritoneal Dialysis Market: Forecast Methodology

Key Players: (this may not be a complete list and extra companies can be added upon request)

 

Baxter International Inc.

Fresenius Medical Care AG & Co. KGaA

Medtronic plc

B. Braun Melsungen AG

Nipro Corporation

Terumo Corporation

DaVita Inc.

Dialysis Clinic, Inc.

Asahi Kasei Medical Co., Ltd.

Renal Care Group, Inc.

Choose License Type

  • Single user license: $3,465.00
  • Multi user license: $4,465.00
  • Corporate license: $5,465.00
Request Sample

Discounts available for multiple report purchases.

  • Comprehensive
    Research Study

    Navigate market complexities confidently with our thorough research study, illuminating pathways to success for your business.

  • Security &
    Confidentiality

    We employ robust security measures to protect your data, ensuring peace of mind throughout the research process.

  • Service
    Assurance

    We uphold the highest standards of integrity and professionalism, delivering trustworthy insights you can depend on.